Addressing Common Medications That Influence Immunotherapy Response in Solid Tumors.
Publication
, Journal Article
DeVito, N; Gray, E; Schrum, D; Antonia, S
Published in: J Clin Oncol
March 2026
Duke Scholars
Published In
J Clin Oncol
DOI
EISSN
1527-7755
Publication Date
March 2026
Volume
44
Issue
7
Start / End Page
529 / 533
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
DeVito, N., Gray, E., Schrum, D., & Antonia, S. (2026). Addressing Common Medications That Influence Immunotherapy Response in Solid Tumors. J Clin Oncol, 44(7), 529–533. https://doi.org/10.1200/JCO-25-01811
DeVito, Nicholas, Erica Gray, Daniel Schrum, and Scott Antonia. “Addressing Common Medications That Influence Immunotherapy Response in Solid Tumors.” J Clin Oncol 44, no. 7 (March 2026): 529–33. https://doi.org/10.1200/JCO-25-01811.
DeVito N, Gray E, Schrum D, Antonia S. Addressing Common Medications That Influence Immunotherapy Response in Solid Tumors. J Clin Oncol. 2026 Mar;44(7):529–33.
DeVito, Nicholas, et al. “Addressing Common Medications That Influence Immunotherapy Response in Solid Tumors.” J Clin Oncol, vol. 44, no. 7, Mar. 2026, pp. 529–33. Pubmed, doi:10.1200/JCO-25-01811.
DeVito N, Gray E, Schrum D, Antonia S. Addressing Common Medications That Influence Immunotherapy Response in Solid Tumors. J Clin Oncol. 2026 Mar;44(7):529–533.
Published In
J Clin Oncol
DOI
EISSN
1527-7755
Publication Date
March 2026
Volume
44
Issue
7
Start / End Page
529 / 533
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis